Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual antiplatelet treatment (DAPT) on atherothrombotic compli...
Guardado en:
Autores principales: | Dimitrios Alexopoulos, Charalampos Varlamos, Despoina-Rafailia Benetou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7cd2d99bafad4623b7befa5181ab0d7c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021) -
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
por: Charalampos Varlamos, et al.
Publicado: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
por: Iosif Xenogiannis, et al.
Publicado: (2021) -
Role of Intravascular Ultrasound in Guiding Complex Percutaneous Coronary Interventions
por: Brandon Quintana, et al.
Publicado: (2020)